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The  present  series  of  studies  has  involved the  transfer  to  a  homologous 
recipient of lymph node cells from rabbits injected with Shigella  paradysen- 
teriae  or of lymph node cells incubated in vitro with soluble antigenic material 
derived from this organism. Following the transfer of such cells,  agglutinins to 
Shigella have been found in the sera of the recipient rabbits (1, 2), and there 
has been evidence that  the  transferred cells have some physiological role in 
the production of this  antibody. There are  thus  aspects  of the  lymph node 
cell transfer system which are parallel to other areas of tissue transplantation, a 
field in which there has recently been a considerable body of experimental work, 
especially in the transplantation of skin  (3). It seemed likely that the appli- 
cation of methods in  the studies  of tissue  transplantation  to the transfer of 
lymph node ceils might shed some light on the mechanisms involved in lymph 
node cell transfer or on factors involved in transplantation immunity. In early 
experiments of this kind it was observed that if the prospective recipients of 
lymph  node  cells  were  injected  a  week  before  the  cell  transfer  with  blood 
leucocytes of the prospective donors,  agglutinins  did not appear  in  the  sera 
of the recipients in the usual manner, a  finding which suggested an effect on 
the transferred cells of a  specific alteration in their new, host-tissue environ- 
ment as  a  result of the pre-injection of the recipient (4).  Further studies in 
this area are reported below. 
Materials and Methods 
Pre-Injec~ion of Donor Leucocytes.--Blood from prospective  donors was obtained by cardiac 
puncture and collected  with hepafin (3 rag. per 50 hal. of blood). To this volume of blood  was 
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added an equal volume of a 3 per cent solution of gelatin in 0.75 per cent NaCI.  I The tubes 
were maintained  in the vertical position in an ice bath.  After 1 hour the sedimentation of 
erythrocytes was such that the overlying columns of fluid could be collected by suction. The 
leucocytes were sedimented from the pooled supemates by centrifugation at 2000 R.P.~.  for 
10 minutes, and were then washed with Tyrode's solution. Various amounts of the suspensions 
of leucocytes were injected intradermally in a number of sites on the backs of the prospective 
recipients. 
Cell Transfer.--Lymph  node cells were obtained  from the popllteal and  axillary lymph 
nodes of donor rabbits, in some cases from those donors whose blood leucocytes had been used 
for pre-injection and in other cases from unrelated donors, in accordance with the protocol of 
the experiment. The cells were washed in Tyrode's solution containing 12.5 per cent gelatin. 
Approximately 225  X  106 cells were incubated with  1 ml. of a  10  ~  dilution of filtrate of 
trypsin-treated Shigdia  paradysenteriae (ST)  at  37°C.  for 30 minutes.  The cells were then 
washed 3 times in Ty'rode gelatin solution and finally suspended in Tyrode's solution contain- 
ing 0.5 per cent of bovine plasma albumin (Armour & Co., Chicago) 
Serologic. Te~t~.--Serial  2-fold dilutions of rabbit serum were made in volumes of 0.4 ml. To 
these were added 0.2 ml. of a 0.06 per cent suspension of alcohol-treated Shigdla paradysen- 
eeriae. After shaking and 1 hour of incubation at 37°C.,  the tubes were stored at 4°C. for 48 
hours, and then examined for evidence of agglutination, as described in detail previously (5). 
Irradiation of Rezi/yicnt Rabbits.--The animals were exposed,  on the day before cell transfer, 
to 425 roentgens of deep Roentgen rays, with the following factors: 200 kv., 20 ma., 67.5 cm. 
distance to the bottom of the container, fielding 18 r per minute in air. Filtration was by 1 
mm. aluminum +  0.5 mm. copper. 
EXPERIMENTAL 
1.  Variations  in  Interval  between the Pre-Injection  of Donor Leucocytes and 
Lympk  Node  Cell  Transfer.--Leucocytes  were  obtained  from  the  blood  of  a 
group of prospective donors and injected intradermally on the backs of pros- 
pective  recipients  at  various  intervals  prior  to  lymph  node  cell  transfer.  On 
the  appropriate  day  the  same  donors were sacrificed,  and  the  popliteal  and 
axillary  lymph  nodes excised.  Cells obtained  from the nodes were incubated 
in  vitro  with  ST  (Skigella-trypsin)  filtrate,  washed,  and  then  transferred  to 
the  pre-injected  recipients,  which had  been  irradiated  24 hours  earlier.  Sera 
of  the  recipients  obtained  at  regular  intervals  after  transfer  were  tested  for 
the presence of agglutinins  to SkigeUa paradysenteriae.  In  the  sera of control 
(non-pre-injected)  recipients,  agglutinins  appeared  on  the  4th  day  after 
transfer and generally reached a maximal titer by the 6th  to 8th  day.  In the 
sera  of  recipients  pre-injected  1  day  prior  to  transfer,  agglutinins  appeared 
at the same time and followed the same pattern as in the controls. Among the 
recipients  pre-injected  2  days  before transfer  there  were many  which  devel- 
oped  agglutinins  to Shigella  in  lower titer  than  the  controls.  The geometric 
mean peak titer of this group of recipients was markedly lower than the mean 
of  the  controls  or  the  group  of  1  day  pre-injected  animals.  With  increasing 
time between the pre-injection of donor leucocytes and lymph node cell trans- 
1 We are indebted  to Kind and Knox Gelatine  Co.,  Camden,  New Jersey,  and  to Dr.  D. 
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fer, lower geometric mean peak titers of the recipients' sera were found, and 
with an interval of 6 to 9 days the recipients' titers were at the limit of de- 
tectable agglutinin  level in  the present system of measurement or below it. 
The relation found between the mean peak agglutinin titers and the pre-injec- 
tion interval is shown in Fig.  1 by the line connecting the solid circles. The 
data  obtained  in  such  experiments are  summarized  in  Table  I,  which  in- 
cludes also data obtained at pre-injection intervals up to 107 days. The maxi- 
mum serum titer for each recipient was tabulated, and the titers were grouped 
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FIe. I. Geometric  mean peak agglutlnin titers of recipient rabbits pre-injected with leuco- 
cytes of other (donor) rabbits at various intervals prior to lymph node cell transfer. The lymph 
node cells had been incubated in vitro with Shigdla-trypsin  filtrate or had been obtained from 
donor rabbits injected with whole  Skigdla,  I, 2, or 3 days before the cell transfer. 
at 3 levels: 128 or higher, i.e.  titers which approached or were similar to the 
controls, 24 to 96, titers which indicated partial reduction in comparison with 
the control titers, and < 12 to 16, which reflected almost complete suppression 
of agglutinin  formation.  The percentage frequency of  titers  within  each  of 
these three ranges, as well as the geometric mean, are shown for the recipients 
pre-injected at each of the intervals employed. It can be seen that at a 6 day 
pre-injection interval all  the pre-injected recipients failed to  develop serum 
agglutinins. The distribution was quite similar for greater intervals, up to 20 
days.  With  larger  intervals  the  percentage of titers  showing  complete sup- 
pression decreased, and the percentage showing partial suppression increased, 
as did the geometric mean titers. The longest interval tested was  107  days, 24  STUDIES ON TRANS~'ER OF LYMPH NODE CELLS.  XI 
at  which  time  there  was still  evidence  of partial  reduction  of fiters,  with  a 
mean titer of 3 powers of 2 below that of the control group. 
These data were obtained with the pre-injection of approximately  10 X  l0  s donor leuco- 
cytes. It was found that the relation between the pre-injection interval and the effectiveness 
of the pre-injection shown in Fig. 1 was altered when larger numbers of leucocytes were in- 
jected. Thus, in some experiments 250 to 500 X los leucocytes were pre-injected and a marked 
reduction in serum titer was observed when the interval  between pre-injecfion and transfer 
was only i' day. 
TABLE I 
E.ffea of Pre-Injeaion  of Donor Leucocyles on Agglutinin  Tilors of Recipients of Lymph Node 
Cells Incubated in Vitro with ST Filtrate 
Interval between pre- 
injection of donor 
leucocytes and cell 
transfer 
days 
(No pre-injection) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
20 
35 
65 
75 
90 
107 
No. of 
recipients 
69 
6 
14 
6 
8 
12 
6 
26 
15 
12 
3 
5 
5 
4 
4 
8 
Agglutinln  titers of recipients 
Percentage occurrence in the range of 
128 or higher  24 to 96  <12 to 16 
81 
100 
57 
17 
19 
7 
50 
50 
25 
11 
25 
40 
75 
75 
100 
36 
33 
50 
75 
100 
89 
100 
92 
100 
75 
60 
25 
25 
Geometric mean 
titer of 
group 
logt 
8.6 
9.3 
6.4 
5.3 
3.6 
3.3 
2.8 
2.9 
2.6 
2.7 
2.5 
3.7 
4.5 
4.7 
4.8 
5.1 
The  foregoing experiments  all  involved  the  transfer  of  lymph  node  cells 
incubated  in  vitro  with  ST filtrate.  It was  of interest  to  determine  whether 
pre-injection  of  donor  leucocytes  would  affect  subsequent  serum  titers  of 
recipients  of  popliteal  lymph  node  cells  from  antigen-injected  donors.  Ac- 
cordingly, recipient rabbits were pre-injected  intradermally with donor leuco- 
cytes at  various  intervals  prior  to cell  transfer.  On  the  day of transfer  cells 
were obtained from lymph nodes regional to injections of Shigella, which had 
been made  1,  2,  or 3  days earlier.  These  cells were transferred  to the pre-in- 
jected  recipient  rabbits.  The  peak  agglutinin  titers  of  these  recipients  were 
tabulated  according  to  the  donor interval  (the  interval  between  injection  of 
antigen  into  the  donor and  collection  of its  lymph  node cells)  and  the  pre- T.  N.  HARRIS,  S.  HARRIS, AND M.  B.  FARBER  25 
injection interval (the interval between pre-injection of donor leucocytes and 
cell transfer), and the geometric mean peak titer of each group was calculated. 
For each interval the mean titers were plotted against the pre-injection inter- 
vals, and it can be seen in Fig.  1 that in each case the pre-injection of donor 
leucocytes at  appropriate times affected the peak titers of recipients.  In the 
case of lymph node cells of a  1 day donor interval the curve of mean aggluti- 
nin titer versus pre-injection interval is similar to that observed  in  the  case 
of lymph node  cells incubated  in  vitro  with  the antigen.  In the  case of cells 
obtained at a 2 day donor interval the curve is similar in shape to the others, 
but  with  a  difference  of  1  day in  pre-injection  interval  corresponding  to  a 
TABLE II 
Injection of Donor Leucocytes  into Recipient Rabbits Prior to Lymph Node Cell Transfer: E.ffects 
of Varying the Number of Leucocytes and the Route of Injection 
No, of donor leucocytes pre-injected 
l0  s 
10  7 
l0  s 
l0  s 
Agglutinin  titers of recipients 
No. of rabbits 
6 
26 
26 
10 
Geometric mean titer 
logs 
3.0 
2.8 
4.1 
6.3 
No pre-injection 
Route of pre-injection  with donor 
leucocytes 
40  8.8 
Mean  titers (logs) of groups of rabbits injected  with various 
numbers of donor leucocytes 
10s  l0  T  l0  s  10  4 
Intradermal  2.5  2.6  3.8  6.5 
Intravenous  3.5  2.6  4.4  5.8 
given mean level of agglutinin. In the case of cells obtained at a  3 day donor 
interval the  curve is again of similar shape,  with a  difference of 1 to 2 days 
from the curve obtained with cells at the 2 day donor interval. 
2. Pre-Injection of Varying Numbers of Donor Leucocytes by Two Routes.--An 
interval  between  pre-injection  of  donor  leucocytes  and  transfer  of  in  vitro- 
incubated  lymph  node  cells  was  chosen  which  could  be  expected  to  cause 
essentially complete suppression of agglutinin production in the recipient, i.e. 
6  or 7  days,  and  the effect of varying the number and route of injection  of 
donor  leucocytes was studied.  It was found  that  the  agglutinin  titers of the 
recipients were a  function of the number of donor leucocytes pre-injected. In 
the upper part of Table II are given the mean agglutinin titers of groups of 
recipients pre-injected with  various  numbers  of donor  leucocytes.  It  can  be 
seen that with  l0 s and  107 leucocytes the recipient mean titers are similar to 26  STUDIES  OF TRANSFER  OF LYMPH NODE CELLS. XI 
each other and similar to the levels shown in Fig. 1. The mean titer was higher 
when 10  e leucocytes were injected, and still higher following the pre-injection 
of 10  6 leucocytes. Even at the last level there was still a difference of 2.5 pow- 
ers of 2  between the mean  titers of pre-injected recipients and those of the 
control recipients, which were not pre-injected. 
In comparing the effectiveness of the intradermal  and intravenous routes 
of injecting donor leucocytes, no consistent difference could be found over the 
range of 10  5 to 10  8 leucocytes, as can be seen in the lower half of Table II. After 
pre-injection by the intradermai route the mean titers were somewhat lower 
than after intravenous injection at doses of 10  8 and  10  e leucocytes, equal at 
10  7  , and somewhat higher at 10  6  . 
3. Pre-Injection  of Cells of Various  Sources.--In  a  number of experiments 
leucocytes obtained from sources other than  the blood of rabbits  were pre- 
injected into recipients 6  to 7 days prior to transfer. Following the transfer 
of in vitro incubated lymph node cells the geometric mean peak titer was cal- 
culated for recipients pre-injected with lymph node cells,  leucocytes of peri- 
toneal exudates,  thymus cells,  or blood leucocytes of rabbits.  It  was  found 
that  after pre-injection with  cells from any of these sources the  titers were 
reduced to approximately the same degree, as is shown in the upper part of 
Table III. 
Leucocytes were obtained from the blood of chicken, cow, horse, and man. 
Approximately l0  T such leucocytes were injected intradermally into recipients 
6  to 7 days before transfer of in vitro-incubated  lymph node cells.  The geo- 
metric  mean  peak  titer  was  calculated  for each  group  and  compared with 
that of the control group. As can be seen in the lower part of Table III, mean 
titers  of recipients pre-injected with  leucocytes of chicken,  cow,  and  horse 
were fairly similar to that of the controls. In the case of recipients pre-injected 
with  human  leucocytes the  mean  titer was  lower than  that  of  the  control 
group, but higher than the groups pre-injected with rabbit leucocytes shown 
in the upper half of the table. 
In some of these experiments erythrocytes were obtained from rabbit blood 
with  as little contamination as possible by leucocytes (1:1000)  and used in 
equal numbers for pre-injection of rabbits. On subsequent cell transfer it was 
found that the mean peak titer of recipients pre-injected with rabbit erythro- 
cytes was quite similar to that of the non-pre-injected controls, as shown in 
the lower part of Table III. 
4. Pre-lnjection  of Leucocytes from Individual Rabbits, Followed by Transfer 
of Lymph  Node  Cells from  the Same  or Other Rabbits.--In  the  experiments 
described thus far, pooled leucocytes of 6 to 8 donor rabbits were used for pre- 
injection, and pooled lymph node cells obtained from the same group of donors 
were used for in vitro incubation with antigen and transfer. Subsequently, it 
was found that pre-injection of pooled leucocytes of one group of donors fol- T.  N.  HARRIS,  S.  HARRIS,  AND M. B. ~ARBER  27 
lowed by transfer of incubated lymph node cells pooled from another set of 
donors yielded the same results, i.e. failure of agglutinins to appear after trans- 
fer.  This result was  obtained in  all  such  experiments performed. It was  of 
interest to obtain some data on the frequency with which the pre-injection of 
leucocytes of any single rabbit would affect the agglutinin titer of a recipient 
of antigen-incubated lymph node cells of another single rabbit. In such experi- 
ments each pair of recipients was injected with leucocytes from 1 rabbit and 
TABLE III 
Geometric Mean Peak Titers of Groups of Recipient Rabbits Pre-lnjected with Cells of Various 
Tissues of Rabbits, and Leucocytes of Other Species 
Experiments involving pre-injection of cells obtained from rabbits. 
Blood leucocytes  ............................ 
Lymph  node cells  ........................... 
Peritoneal exudate cells  ...................... 
Thymus  cells  ............................... 
No pre~injection (controls in above experiments) 
No. of  No. of  Geometric 
experiments  recipients  mean titer 
15 
10 
10 
7 
12 
loss 
3.2 
3.0 
3.3 
3.6 
8.3 
Experiments involving pre-injection of cells obtained from other  species, and  rabbit 
erythrocytes. 
Leucocytes of  No. of  No. of  Geometric 
experiments  recipients  mean titer 
Chicken .................................... 
COW ........................................ 
Horse  ....................................... 
Man ........................................ 
Erythrocytes of rabbit ........................ 
No pre-injection (controls  in above experiments). 
5 
5 
7 
10 
16 
13 
log~ 
7.2 
7.3 
7.5 
5.3 
7.4 
7.6 
antigen-incubated  lymph  node  cells  from  another.  Two  pairs  of  recipients 
received both leucocytes and lymph node ceils pooled from all the donors of 
the experiment, and in two other instances 1 of the donors of leucocytes for 
pre-injection also served as a source of lymph node cells.  The individual peak 
recipient titers obtained in a  number of experiments are shown in Table IV. 
As can be seen in this table, the 10 pairs of recipients of blood leucocytes and 
lymph  node  cells from different, single,  rabbits  included seven instances in 
which  the  agglutinin  titers  of both  recipients were  below  the  threshold  of 
measurement or were low; in two cases the titer of 1 recipient was low but 
that of the 2rid recipient was similar to or higher than the controls; and in 1 28  STUDIES ON TRANSFER OF  LYMPH NODE CELLS. XI 
pair,  both recipients developed titers in  the middle range,  below that  of the 
controls. 
5.  Pre-Injection of Recipients with  Their Own Leucocytes or with Leucocytes 
of Other Rabbits.--The  effect of pre-injection  of a  recipient's own leucocytes 
was  studied  in  three  experimental  situations.  In  one  of  these,  the  recipient 
was bled and a  leucocyte suspension was prepared and injected intradermally 
into  the same recipient;  in another,  the same procedure was followed except 
that the leucocytes were injected intravenously, and in the third, whole blood 
was collected from the  recipient  and re-injected  intravenously.  In each  case 
TABLE IV 
Maximum Agglutinin Titers of Recipients Pre-Injected with Leucocytes of Indinidual Donors 
and Given Incubated Lymph Node Cells  from Other Donor Rabbits 
Donors  of  Peak agglutlnin titers of individual recipients 
Leucocytes for  Lymph node  cells  Pre-injected  Not pre-injected 
pre-injection  for transfer 
A 
B 
C 
D 
Pooled A-D 
I 
J 
K 
L 
Pooled I-L 
O 
Q 
S 
S 
E 
F 
G 
H 
Pooled E-H 
M 
N 
O 
P 
Pooled M-P 
Q 
R 
S 
T 
<12  <12 
<12  <12 
32  1024 
24  24 
<12  <12 
<12  32 
16  24 
64  192 
<12  12 
<12  <12 
<12 
<12  384 
16 
<12  <12 
192 
192 
1536 
1536 
384 
768 
1024 
recipients other than the one bled were also injected with the leucocytes. One 
week  later  all  of  the  recipients  were  given  antigen-incubated  lymph  node 
cells pooled from a  group of donor rabbits. The peak agglutirdn titer for each 
recipient  was  determined,  and  for  each  experimental  group  the  percentage 
frequency  of  these  titers  was  calculated  for  the  higher,  middle,  and  lower 
range. These results are given in Table V. Within both the intradermally and 
intravenously  injected  groups  the  differences in  findings  between  the  recipi- 
ents injected with their own leucocytes and those injected with leucocytes of 
other rabbits were marked. The percentage frequency of titers above 128 was 
high  in  the group of recipients injected  with  their own cells and  low in  the 
groups  injected  with  other  cells.  Conversely,  the  percentage  frequency  of T. N. HARRIS, $. HAI~I$~ AND M. B.  FARBER  29 
titers of  < 12  to  16 was very low in the groups injected with their own cells 
and high in the groups injected with other rabbits' cells. In a  comparison of 
rabbits  pre-injected  with  their  own  cells  and  those  not  pre-injected  at  all, 
the percentage-frequency distribution of titers was found to be fairly similar, 
but  with  the  following  differences:  first,  the  occurrence  of  titers  of  128  or 
higher was somewhat lower in  the groups pre-injected with  their own leuco- 
cytes than in the controls, and second, of the rabbits pre-injected with their 
own leucocytes a  small  percentage failed  to  develop measurable agglutinins 
or did so in very low titer, whereas in the control group this did not occur. 
TABLE V 
Pre-lnjection  of Each Recipient with Its Own Leucocytes or Whole Blood, or with Cells of Another 
Rabbit 
Groups of experiments 
Intradermal pre-injection of blood leucocytes 
(a)  None .... 
(b)  Own cells. 
(c)  Cells  of other rabbits. 
Intravenous pre-injection of blood leucocytes 
(a)  None... 
(b)  Own cells. 
(c)  Cells  of other rabbits. 
Intravenous pre-injection of whole blood 
(a)  None. 
(b)  Own blood. 
(c)  Blood of other rabbits. 
No. of 
recipients 
11 
18 
17 
12 
26 
15 
Agglutinin titers of recipients 
Percentage occurrence  in the range of 
128 or higher  24 to 96  ~  12 to 16 
82 
72 
24 
11 
21 
13 
83 
77 
20 
18 
22 
35 
17 
19 
27 
18 
19 
46 
82 
81 
23 
0 
6 
41 
0 
4 
53 
0 
0 
31 
In the case of recipients injected intravenously with whole blood, the results 
obtained in the groups of recipients injected with their own blood were  indis- 
tinguishable  from those in  control,  non-pre-injected  recipients.  The findings 
in  the group of recipients injected with blood of other recipients were fairly 
similar to those found in the case of leucocytes of other rabbits except for a 
shift between the occurrence of very low and moderately low titers, indicating 
somewhat less suppression of agglutinin formation in these recipients than in 
those  pre-injected  with  suspensions  of  leucocytes,  either  intradermally  or 
intravenously. 
6. Effect of Various  Treatments of Leucocytes Prior to Pre-lnjection.--Leuco- 
cytes obtained from donor rabbits' blood were treated in a  number of ways 
and  then  injected  intradermally  into  recipients.  The  treatments  included 
heating  for 60 minutes at 60°C.,  alternate freezing in a  dry ice alcohol bath 
at  -70°C.  and  thawing,  suspension  of  the  cells  in  distilled  water,  addition 30  STUDIES ON TRANSFER OF LYMPH NODE CELLS. XI 
of  sodium  iodoacetate  to  10  -2 M,  lyophilization,  x-irradiation  at  400  r,  and 
oscillation  in  a  magnetostriction  oscillator  (Raytheon  Manufacturing  Co., 
Boston)  for 1 hour. One week after pre-injection of the recipients with treated 
leucocytes, antigen-incubated  lymph node cells pooled from the same donors 
were  transferred  to these  recipients.  Within  each group  the geometric mean 
peak agglutinin  titer was calculated,  as well as the percentage frequency of 
titers within the ranges of 128 or higher, 24 to 96 and  < 12 to 16. The results 
are shown in Table VI. It was found that all treatments except oscillation and 
x-irradiation resulted in a loss of the capacity of the leucocytes to bring about 
the pre-injection effect. Within this group, the loss was more nearly complete 
TABLE VI 
Effect on the Agglutinin Titers of Recipient Rabbits of the Pre-lnjextion of Donor Leucocytes 
Treated in Various Ways 
Treatment of donor leucocytes 
So pre-injection (controls) 
~Ieating. 
[odoacetate. 
Freezing. 
Distilled water. 
[~yophilization... 
~onic oscillation 
Whole suspension. 
Sediment. 
Supernate. 
K-irradiation  .... 
Untreated. 
No, Of 
recipients 
22 
10 
i0 
6 
15 
10 
Agglutinin titers of recipients 
Percentage occurrence  in  the range of: 
128 or higher 
77 
80 
70 
67 
67 
70 
16 
5 
5 
6 
17 
0 
0 
100 
0 
0 
24 to 96  <  12 to 16 
23  0 
20  0 
30  0 
33  0 
33  0 
30  0 
13  87 
20  80 
0  0 
17  83 
6  94 
Geometric 
mean titer 
of group 
/ogt 
7.2 
7.3 
7.0 
6.6 
6.0 
6.5 
2.9 
3.3 
7.1 
2.8 
3.0 
and consistent in the case of some treatments, heating or treatment with iodo- 
acetic  acid,  than  in  the  others,  suspension  in  distilled  water,  lyophilization, 
and freezing and thawing. X-irradiation and oscillation of the leucocytes ap- 
peared to have no effect on the capacity of these ceils to bring about the pre- 
injection  effect. When  oscillated suspensions were centrifuged and  supernate 
and  sediment  injected  separately the  active material appeared  to  be in  the 
sediment. 
DISCUSSION 
A.  The  Effect  of  Pre-Injeclion  of  Donor  Leucocytes  on  Lymph  Node  Cell 
Transfer.--It  is  clear,  from  the  data  presented  above,  that  the  results  of 
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of blood leucocytes from the donors of the lymph node cells, if the leucocytes 
are injected at a  sufficient interval before the  cell transfer and  in sufficient 
numbers relative to this interval. Such an effect, as indicated by lower con- 
centrations  of agglutinins  to Shigdla  in  the  sera  of  recipient  animals,  was 
demonstrated under various experimental conditions: in  terms of the  trans- 
ferred lymph node cells, whether these had been incubated in vitro with Shi- 
gella-trypsin  filtrate or whether they had been obtained from donors injected 
previously with Shigdla; in terms of the pre-injected leucocytes, whether these 
were pooled from groups of rabbits which were to be used as donors of the 
transferred  lymph  node  cells  or pooled from groups  of rabbits  other  than 
the  lymph  node cell  donors,  or,  in  some  cases,  even  from  individual  rab- 
bits,--either  the  prospective donors  of the  transferred lymph node  cells  or 
others. 
That this  "pre-injection effect" is immunologic in nature  is suggested by 
several observations. First,  the intervals between the pre-injection of leuco- 
cytes and the lymph node cell transfer which is required for the partial and 
the complete effect, respectively, are consistent with the time after injection 
of cellular antigens  at which  one could expect the appearance of significant 
and maximal titers of antibody. (To the 2 day and 6 day intervals indicated 
in Table I  and Fig.  1 for the partial and complete effects, respectively, on in 
vitro incubated cells,  should be added 3 days, the time after transfer of such 
cells that anti-Shigdla antibody appears.  It should also be noted that  these 
intervals are decreased when larger numbers of donor leucocytes are used for 
the pre-injection.) Further evidence of an immunologic mechanism based on 
rabbit leucocyte antigens is offered by the species specificity of the reaction-- 
that the pre-injection of leucocytes of several mammalian species other than 
the rabbit failed to affect the results of subsequent transfer of rabbit lymph 
node cells.  Finally, an immunologic mechanism is suggested by the failure of 
pre-injection of the recipient's own leucocytes to affect substantially its sub- 
sequent agglutinin titer: in this case no new cell antigens of rabbit leucocytes 
would be introduced into the recipient's tissues. 
The first experiments on this point indicated a dear difference between the effects 
of the recipient's own leucocytes pre-injected intradermaUy or intravenously and those 
of other rabbits (upper two-thirds of Table V). However, the data in the first two rows 
of these sections of the table indicated a slight difference between rabbits pre-injected 
with their own leucocytes and the non-pre-injected  controls, in that the former group 
contained somewhat fewer titers in the highest range and 1 rabbit in the lowest range 
of titers. The question arose as to whether the manipulation of the blood in concentra- 
ting the leucocytes could have caused enough denaturation of leucocyte proteins to 
have rendered some of these slightly antigenic to the rabbit from which the blood was 
drawn.  Accordingly, the experiments  were repeated with leucocytes as they occur in 
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lation,  in amounts containing the same number of leucocytes as hitherto.  In these 
experiments  (lowest part  of Table V)  the  results  were  no different following pre- 
injection of the recipient's own blood or no pre-injection  at all; however,  the pre- 
injection of blood of other rabbits did cause a substantial difference  in the distribution 
of the subsequent agglutinin titers of the recipient rabbits. This difference  was fairly 
similar to that found in recipients pre-injected with prepared suspensions of leucocytes 
of other rabbits but with somewhat less reduction in titers. These data again support 
the conscluion that the effects  of pre-injection of leucocytes reported here are due to 
differences  in antigenic structure  in leucocytes among members of the species,  but 
indicate that a small part of the effect of leucocyte pre-injection on the lymph node 
cell  transfer  observed throughout this  study could be due  to changes in leucocyte 
protein per se. 
Thus  the  effect  of pre-injection  of  leucocytes  on  subsequent  lymph  node 
cell transfer would seem to rest on individual tissue specificity within members 
of  the  rabbit  species.  This  interpretation  would  also  be  consistent  with  the 
finding  that  substantial  pre-injection  effects were  obtained  invariably  in  the 
case  of leucocytes pooled from several  rabbits,  and  sporadically  in  the  case 
of leucocytes from individual rabbits. 
The data obtained following the pre-injection of leucocytes from single rabbits is of 
interest from the point of view of the random distribution of the individual antigens 
involved in tissue specificity. The experiments shown in Table IV involved the pre- 
injection of leucocytes from 1 rabbit to 2 recipients, and the transfer to the latter of 
lymph node cells from another individual rabbit. A number of immunologic relation- 
ships could exist among these animals, which would determine the outcome of such 
experiments. If the donor of the pre-injected leucocytes and that of the lymph node 
cells have at least one common antigen which the recipient does not have, and  to 
which it is  therefore able  to react immunologicaUy, one could expect a  substantial 
degree of "suppression" of the transferred  cells  (reduction in subsequent agglutinin 
titer of the recipient).  On the other hand, if the 2 donor rabbits have no common 
antigen, or if they have common antigens but the recipient also has any antigen com- 
mon to both donors, and is thus unable to react immunologically to it, one would 
expect no "suppression" of the cells, i.e., no reduction in titers. Intermediate recipient 
agglutinin  fiters,  indicating  partial  "suppression"  of  the  transferred  cells,  would 
reflect degrees of effective antigenicity of the tissue factors, perhaps on the basis of 
smaller differences  in configuration between antigenic groupings of the tissue factors 
involved. In a random population, such as the rabbits used here, it would therefore be 
possible to encounter any combination of results in experiments such as those shown 
in Table IV. The fact that of 20 recipients shown in that table as receiving the pre- 
injected and the transferred  cells from 2 different rabbits  16 had markedly reduced 
titers would suggest that the total number of individual tissue antigens in leucocytes of 
rabbits  is  considerable,  and  that  each  animal  carries  several  of these,  so  that  the 
probability  of a  common antigen  in  the leucocytes of 2 rabbits  chosen at random 
would be high, but that each animal has substantially less than half the total number, 
so that the probability that a randomly chosen recipient would not have the antigens 
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B. Implication  of These Data as to the Function of the Transferred Cells.--The 
data  obtained  in  this  study,  and  the  discussion  above,  suggest  that  in  this 
experimental situation the pre-injection of homologous leucocytes has caused 
an alteration in the host tissue environment into which  the lymph node cells 
are  transferred,  this  alteration  being  specific with  respect  to the  transferred 
cells. The fact that this alteration results in the failure of appearance of anti- 
body, such as would be expected after the transfer of antigen-incubated lymph 
node cells, supports the thesis that a  function of the transferred lymph node 
cells is involved in the production of the antibody normally found under these 
circumstances. 
This thesis is further supported by the data obtained with  the  transfer of 
cells from antigen-injected donor rabbits. 
In the early studies of this series lymph node cells were transferred from rabbits 
which had been injected with ShigeUa. It was found that if the lymph node cells were 
obtained 3 days after the injection of the donor animal with the antigen, antibody 
appeared in the recipient 1 day after cell transfer. If less time was allowed  between 
injection and sacrifice of the donor, 2 days or  1 day, detectable levels of antibody 
appeared in the serum of the recipient at longer intervals after cell transfer, 2 and 3 
days respectively. Thus it appeared that the transferred cells were involved in a process 
which required a given time--about 3 days--between contact of lymph node cell with 
antigen and appearance of detectable concentrations of antibody in the recipient's 
serum. Returning to the data of the present study, it can be seen in Fig.  1 that the 
transfer of 3 day cells (i.e. ceils obtained from draining lymph nodes 3 days after the 
injection of Shigella into the donors)  is not followed by the appearance of agglutinins 
in the recipients if the latter have been pre-injected 1 week earlier with leucocytes 
from the donor rabbits. Since the transfer of lymph node cells into a specifically adverse 
environment even within  1 day of the time antibody would appear in the recipient 
results in the failure of appearance of that antibody, it seems likely that the function 
of the transferred cells is not merely to contribute some factor which the tissues of the 
recipient can use to undertake the synthesis of the antibody, but rather to carry out 
at least a major part of the synthesis of the antibody themselves. It is also significant, 
in this regard, that the curves relating the effectiveness of pre-injected leucocytes to 
the interval between pre-injection and cell transfer, shown in Fig. 1, are quite uniform 
in the case of all four kinds of transferred lymph node eells--whether these are incu- 
bated in v/tro with the antigen, or obtained 1, 2, or 3 days after injection of antigen 
into the donors--and that these curves are separated by time intervals approximately 
the same as the differences in the time of appearance of antibody after cell transfer, in 
the case of these four preparations of cells. 
C. The Rdationship of These Observations to Those Reported in Studies of Skin 
Grafting.--The  difference  in  observed  events  subsequent  to  the  transfer  of 
lymph node  cells  according  to  whether  the  recipients  are  encountering  cells 
from the  donor for the first  time or  the  second  time  (after pre-injection)  is 
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Medawar reported that a first skin graft of a given donor rabbit to a given recipient 
rabbit was rejected in approximately 10 days, but when a second skin graft from the 
same donor was placed on the same recipient the graft was rejected in 4 to 6 days 
(the "second set" phenomenon)  (6, 7). Thus the difference in response  to a second 
graft involved a difference of time,  in comparison with the time of rejection of a first 
graft, whereas in the present system antibody fails to appear altogether. This differ° 
ence between the two situations is in all probability due merely to the fact that there 
are differences in the respective experimental conditions.  Thus, in the case of skin 
grafting the transplanted tissue must await vascularization for full contact with the 
blood of the recipients, whereas in lymph node cell transfer the transplanted cells are 
introduced directly into the blood by intravenous injection. 
A number of the observations made in this study are analogous to the cor- 
responding  observations  reported  in  studies  of  skin  homografting.  First,  a 
definite minimum interval of time between leucocyte pre-injection and lymph 
node cell transfer was found necessary in this study for the suppressive effect 
on the transferred cells,  and a  certain minimum of time must elapse between 
first and second skin homografts in order to elicit the second set phenomenon 
(7). Second, the accelerated rejection of a  second skin graft in mice was ob- 
served as long as 120 days after the first skin graft was placed (8), and in this 
study some suppressive effect on transferred lymph node cells  was  found as 
long as 107 days after the pre-injection of leucocytes. Third, in this study it 
was found that, within a  given range of numbers of leucocytes pre-injected, 
the degree of suppression of activity of the transferred cells was  a  function 
of the number of leucocytes; in the case of skin homografts Medawar reported 
that the survival time of skin homografts bears an inverse relationship to the 
dose of grafted skin (7). 
Other parallel observations have also been made between the two systems. 
Medawar  (9)  had found that  the second set phenomenon could be induced 
not  only by prior skin grafting but also by the injection of leucocytes; the 
injection of erythrocytes did  not,  however, have  a  similar  effect. Thus  the 
antigens  of rabbit  leucocytes--at least  those  shared  with  skin--were  found 
not to occur in erythrocytes. In the present study there was no evidence of 
common antigens between leucocytes and erythrocytes of the rabbit, in that 
the pre-injection of erythrocyte suspensions did not lead to decreased agglu- 
tinin titers. 
Finally, there have been similarities in the results of treatment of the cells 
injected for the primary contact between the animals.  Of the treatments of 
pre-injected leucocytes found in  this  study to  inactivate  the  effect, several 
(heating,  lyophilization, and freezing) had been applied to rabbit tissue and 
mouse splenic cells in skin grafting studies, with similar effects, i.e.  failure of 
induction of the second set phenomenon (10,  11). Of the two treatments found 
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the latter had been found not to inactivate splenic cells of mice for induction 
of the second set phenomenon (11). Also, the active material has been found 
in both systems to be present in the insoluble sediment of the oscillated cell 
suspension (11). 
One observation made in these studies is at variance with a parallel obser- 
vation  reported  in  the  skin  homografting  studies.  In  preparing  rabbits  for 
accelerated rejection of skin grafts by injection of leucocytes, Medawar found 
intradermal  injections of the leucocytes to be 18 times as effective as intra- 
venous  (9).  Later,  Billingham  and  Sparrow  reported  that  rabbits  injected 
intravenously with suspensions  of homologous,  dissociated, viable epidermal 
cells  (1  to 5 million)  failed to show accelerated skin graft rejection,  and  in 
some of the experimental animals the survival of the graft was increased by a 
factor of 2 or 3  (12).  In the present study no difference  was found between 
the effectiveness of leucocytes pre-injected intravenously or intradermally  in 
the range between l0  s and  108 cells, as shown in Table II.  It may be men- 
tioned in this connection that in the case of pure bred strains of mice, Billing- 
ham et  al. found the intravenous route effective for inducing accelerated skin 
graft rejection by injection of leucocytes (13). 
SUM-MARY 
The transfer  to rabbits of homologous lymph node cells  which have been 
incubated in vitro  with Shigdla-trypsin  filtrate  leads to the appearance of 
agglutinins  to Shigella  in the sera  of the recipients.  In the present study it  has 
been found that the prior injection  of the prospective recipients  with blood 
leucocytes from the donor animals prevented the appearance of anti-ShigeHa 
agglutinins.  The following  observations  have been made in this  system: 
I. The degree of the pre-injection  effect  was found to be a function of the 
number of leucocytes  injected  and of the interval  between such pre-injection 
and the transfer  of the antigen'incubated lymph node cells. 
2. The pre-injection  of leucocytes  at appropriate intervals  could also  cause 
the failure  of antibody to appear in sera  of recipients  of lymph node cells 
when these  were obtained from donor rabbits  injected  with Shigdla,  I, 2, or 3 
days prior  to cell  transfer. 
3.  Agglutinins  failed  to  appear  in  cell-transfer  experiments after  the pre- 
injection not only of blood leucocytes, but also of lymph node cells, peritoneal 
exudate cells, or thymus cells of rabbits. This effect was not brought about by 
pre-injection of erythrocytes of rabbits or leucocytes of chicken,  cow, or horse. 
The pre-injection of leucocytes of human blood had an effect of partial  sup- 
pression. 
4. When the leucocytes for pre-injection were pooled from groups of rabbits, 
either the prospective donors of the lymph node cells or other rabbits, essen- 
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leucocytes for pre-injection were obtained from an individual rabbit and the 
lymph node cells from another rabbit the suppression of the recipients' titers 
occurred sporadically. 
5.  When the  recipient's  own leucocytes were pre-injected  the  subsequent 
agglutinin  titers  were  somewhat  lower  than  those  of  the  non-pre-injected 
controls. When the recipient's whole blood was re-injected as the source of 
leucocytes the subsequent agglutinin fiters were as high as those of the non- 
pre-injected controls. 
6.  The  pre-injection  effect was  not  obtained  if the  leucocytes had  been 
heated, frozen and thawed, suspended in distilled water, lyophilized, or treated 
with  sodium iodoacetate.  However,  sonic  oscillation or x-irradiation of  the 
leucocytes had  no effect on their capacity to  bring  about  the pre-injection 
effect. 
We are indebted to the Department of Radiology of the Graduate Hospital of the University 
of Pennsylvania  for its generosity  in carrying  out the irradiations  of recipient rabbits through- 
out these studies. 
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